Global Pneumonia Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Pneumonia Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Pneumonia Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.2.4 Other
1.3 Market Segment by Application
1.3.1 Global Pneumonia Vaccine Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Sepsis
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Pneumonia Vaccine Market Size (2017-2028)
2.1.1 Global Pneumonia Vaccine Revenue (2017-2028)
2.1.2 Global Pneumonia Vaccine Sales (2017-2028)
2.2 Global Pneumonia Vaccine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Pneumonia Vaccine Sales by Regions (2017-2022)
2.2.2 Global Pneumonia Vaccine Revenue by Regions (2017-2022)
2.3 Global Pneumonia Vaccine Market Size Forecast by Region
2.3.1 Global Pneumonia Vaccine Sales Forecast by Region (2023-2028)
2.3.2 Global Pneumonia Vaccine Revenue Forecast by Region (2023-2028)
2.4 Global Top Pneumonia Vaccine Regions (Countries) Ranking by Market Size
2.5 Pneumonia Vaccine Market Dynamics
2.5.1 Pneumonia Vaccine Market Trends
2.5.2 Pneumonia Vaccine Market Drivers
2.5.3 Pneumonia Vaccine Market Challenges
2.5.4 Pneumonia Vaccine Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Pneumonia Vaccine Manufacturers by Sales (2017-2022)
3.1.1 Global Pneumonia Vaccine Sales by Manufacturers (2017-2022)
3.1.2 Global Pneumonia Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Pneumonia Vaccine Sales in 2021
3.2 Global Top Manufacturers Pneumonia Vaccine by Revenue
3.2.1 Global Pneumonia Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Top Pneumonia Vaccine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Pneumonia Vaccine Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Pneumonia Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumonia Vaccine as of 2021)
3.4 Global Pneumonia Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Pneumonia Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Pneumonia Vaccine Market
3.7 Key Manufacturers Pneumonia Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pneumonia Vaccine Market Size by Type
4.1 Global Pneumonia Vaccine Historic Market Review by Type (2017-2022)
4.1.1 Global Pneumonia Vaccine Sales Market Share by Type (2017-2022)
4.1.2 Global Pneumonia Vaccine Revenue Market Share by Type (2017-2022)
4.1.3 Pneumonia Vaccine Price by Type (2017-2022)
4.2 Global Pneumonia Vaccine Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Pneumonia Vaccine Sales Forecast by Type (2023-2028)
4.2.2 Global Pneumonia Vaccine Revenue Forecast by Type (2023-2028)
4.2.3 Pneumonia Vaccine Price Forecast by Type (2023-2028)
5 Global Pneumonia Vaccine Market Size by Application
5.1 Global Pneumonia Vaccine Historic Market Review by Application (2017-2022)
5.1.1 Global Pneumonia Vaccine Sales Market Share by Application (2017-2022)
5.1.2 Global Pneumonia Vaccine Revenue Market Share by Application (2017-2022)
5.1.3 Pneumonia Vaccine Price by Application (2017-2022)
5.2 Global Pneumonia Vaccine Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Pneumonia Vaccine Sales Forecast by Application (2023-2028)
5.2.2 Global Pneumonia Vaccine Revenue Forecast by Application (2023-2028)
5.2.3 Pneumonia Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pneumonia Vaccine Sales Breakdown by Company
6.1.1 North America Pneumonia Vaccine Sales by Company (2017-2022)
6.1.2 North America Pneumonia Vaccine Revenue by Company (2017-2022)
6.2 North America Pneumonia Vaccine Market Size by Type
6.2.1 North America Pneumonia Vaccine Sales by Type (2017-2028)
6.2.2 North America Pneumonia Vaccine Revenue by Type (2017-2028)
6.3 North America Pneumonia Vaccine Market Size by Application
6.3.1 North America Pneumonia Vaccine Sales by Application (2017-2028)
6.3.2 North America Pneumonia Vaccine Revenue by Application (2017-2028)
6.4 North America Pneumonia Vaccine Market Size by Country
6.4.1 North America Pneumonia Vaccine Sales by Country (2017-2028)
6.4.2 North America Pneumonia Vaccine Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pneumonia Vaccine Sales Breakdown by Company
7.1.1 Europe Pneumonia Vaccine Sales by Company (2017-2022)
7.1.2 Europe Pneumonia Vaccine Revenue by Company (2017-2022)
7.2 Europe Pneumonia Vaccine Market Size by Type
7.2.1 Europe Pneumonia Vaccine Sales by Type (2017-2028)
7.2.2 Europe Pneumonia Vaccine Revenue by Type (2017-2028)
7.3 Europe Pneumonia Vaccine Market Size by Application
7.3.1 Europe Pneumonia Vaccine Sales by Application (2017-2028)
7.3.2 Europe Pneumonia Vaccine Revenue by Application (2017-2028)
7.4 Europe Pneumonia Vaccine Market Size by Country
7.4.1 Europe Pneumonia Vaccine Sales by Country (2017-2028)
7.4.2 Europe Pneumonia Vaccine Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pneumonia Vaccine Sales Breakdown by Company
8.1.1 Asia Pacific Pneumonia Vaccine Sales by Company (2017-2022)
8.1.2 Asia Pacific Pneumonia Vaccine Revenue by Company (2017-2022)
8.2 Asia Pacific Pneumonia Vaccine Market Size by Type
8.2.1 Asia Pacific Pneumonia Vaccine Sales by Type (2017-2028)
8.2.2 Asia Pacific Pneumonia Vaccine Revenue by Type (2017-2028)
8.3 Asia Pacific Pneumonia Vaccine Market Size by Application
8.3.1 Asia Pacific Pneumonia Vaccine Sales by Application (2017-2028)
8.3.2 Asia Pacific Pneumonia Vaccine Revenue by Application (2017-2028)
8.4 Asia Pacific Pneumonia Vaccine Market Size by Region
8.4.1 Asia Pacific Pneumonia Vaccine Sales by Region
8.4.2 Asia Pacific Pneumonia Vaccine Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Pneumonia Vaccine Sales Breakdown by Company
9.1.1 Latin America Pneumonia Vaccine Sales by Company (2017-2022)
9.1.2 Latin America Pneumonia Vaccine Revenue by Company (2017-2022)
9.2 Latin America Pneumonia Vaccine Market Size by Type
9.2.1 Latin America Pneumonia Vaccine Sales by Type (2017-2028)
9.2.2 Latin America Pneumonia Vaccine Revenue by Type (2017-2028)
9.3 Latin America Pneumonia Vaccine Market Size by Application
9.3.1 Latin America Pneumonia Vaccine Sales by Application (2017-2028)
9.3.2 Latin America Pneumonia Vaccine Revenue by Application (2017-2028)
9.4 Latin America Pneumonia Vaccine Market Size by Country
9.4.1 Latin America Pneumonia Vaccine Sales by Country (2017-2028)
9.4.2 Latin America Pneumonia Vaccine Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pneumonia Vaccine Sales Breakdown by Company
10.1.1 Middle East and Africa Pneumonia Vaccine Sales by Company (2017-2022)
10.1.2 Middle East and Africa Pneumonia Vaccine Revenue by Company (2017-2022)
10.2 Middle East and Africa Pneumonia Vaccine Market Size by Type
10.2.1 Middle East and Africa Pneumonia Vaccine Sales by Type (2017-2028)
10.2.2 Middle East and Africa Pneumonia Vaccine Revenue by Type (2017-2028)
10.3 Middle East and Africa Pneumonia Vaccine Market Size by Application
10.3.1 Middle East and Africa Pneumonia Vaccine Sales by Application (2017-2028)
10.3.2 Middle East and Africa Pneumonia Vaccine Revenue by Application (2017-2028)
10.4 Middle East and Africa Pneumonia Vaccine Market Size by Country
10.4.1 Middle East and Africa Pneumonia Vaccine Sales by Country (2017-2028)
10.4.2 Middle East and Africa Pneumonia Vaccine Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Overview
11.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Pfizer Inc. Pneumonia Vaccine Products and Services
11.1.5 Pfizer Inc. Pneumonia Vaccine SWOT Analysis
11.1.6 Pfizer Inc. Recent Developments
11.2 Glaxosmithkline Plc.
11.2.1 Glaxosmithkline Plc. Corporation Information
11.2.2 Glaxosmithkline Plc. Overview
11.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Products and Services
11.2.5 Glaxosmithkline Plc. Pneumonia Vaccine SWOT Analysis
11.2.6 Glaxosmithkline Plc. Recent Developments
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Corporation Information
11.3.2 Merck & Co., Inc. Overview
11.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Merck & Co., Inc. Pneumonia Vaccine Products and Services
11.3.5 Merck & Co., Inc. Pneumonia Vaccine SWOT Analysis
11.3.6 Merck & Co., Inc. Recent Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Overview
11.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Sanofi Pasteur Pneumonia Vaccine Products and Services
11.4.5 Sanofi Pasteur Pneumonia Vaccine SWOT Analysis
11.4.6 Sanofi Pasteur Recent Developments
11.5 Serum Institute of India Pvt. Ltd.
11.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
11.5.2 Serum Institute of India Pvt. Ltd. Overview
11.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Products and Services
11.5.5 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine SWOT Analysis
11.5.6 Serum Institute of India Pvt. Ltd. Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Pneumonia Vaccine Products and Services
11.6.5 Johnson & Johnson Pneumonia Vaccine SWOT Analysis
11.6.6 Johnson & Johnson Recent Developments
11.7 Astellas Pharma Inc.
11.7.1 Astellas Pharma Inc. Corporation Information
11.7.2 Astellas Pharma Inc. Overview
11.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Astellas Pharma Inc. Pneumonia Vaccine Products and Services
11.7.5 Astellas Pharma Inc. Pneumonia Vaccine SWOT Analysis
11.7.6 Astellas Pharma Inc. Recent Developments
11.8 Astrazeneca Plc.
11.8.1 Astrazeneca Plc. Corporation Information
11.8.2 Astrazeneca Plc. Overview
11.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Astrazeneca Plc. Pneumonia Vaccine Products and Services
11.8.5 Astrazeneca Plc. Pneumonia Vaccine SWOT Analysis
11.8.6 Astrazeneca Plc. Recent Developments
11.9 CSL Limited
11.9.1 CSL Limited Corporation Information
11.9.2 CSL Limited Overview
11.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 CSL Limited Pneumonia Vaccine Products and Services
11.9.5 CSL Limited Pneumonia Vaccine SWOT Analysis
11.9.6 CSL Limited Recent Developments
11.10 Emergent Biosolutions
11.10.1 Emergent Biosolutions Corporation Information
11.10.2 Emergent Biosolutions Overview
11.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Emergent Biosolutions Pneumonia Vaccine Products and Services
11.10.5 Emergent Biosolutions Pneumonia Vaccine SWOT Analysis
11.10.6 Emergent Biosolutions Recent Developments
11.11 Walvax Biotechnology
11.11.1 Walvax Biotechnology Corporation Information
11.11.2 Walvax Biotechnology Overview
11.11.3 Walvax Biotechnology Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Walvax Biotechnology Pneumonia Vaccine Products and Services
11.11.5 Walvax Biotechnology Recent Developments
11.12 Royal (Wuxi) Bio-Pharmaceutical
11.12.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
11.12.2 Royal (Wuxi) Bio-Pharmaceutical Overview
11.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Products and Services
11.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
11.13 Zhifei Biologic
11.13.1 Zhifei Biologic Corporation Information
11.13.2 Zhifei Biologic Overview
11.13.3 Zhifei Biologic Pneumonia Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Zhifei Biologic Pneumonia Vaccine Products and Services
11.13.5 Zhifei Biologic Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pneumonia Vaccine Value Chain Analysis
12.2 Pneumonia Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pneumonia Vaccine Production Mode & Process
12.4 Pneumonia Vaccine Sales and Marketing
12.4.1 Pneumonia Vaccine Sales Channels
12.4.2 Pneumonia Vaccine Distributors
12.5 Pneumonia Vaccine Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Pneumonia Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Pneumococcal Conjugate Vaccine (PCV13)
Table 3. Major Manufacturers of Pneumococcal Polysaccharide Vaccine (PPSV23)
Table 4. Major Manufacturers of Other
Table 5. Global Pneumonia Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Pneumonia Vaccine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Pneumonia Vaccine Sales by Region (2017-2022) & (K Doses)
Table 8. Global Pneumonia Vaccine Sales Market Share by Region (2017-2022)
Table 9. Global Pneumonia Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Pneumonia Vaccine Revenue Market Share by Region (2017-2022)
Table 11. Global Pneumonia Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 12. Global Pneumonia Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Pneumonia Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Pneumonia Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Pneumonia Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Pneumonia Vaccine Market Trends
Table 17. Pneumonia Vaccine Market Drivers
Table 18. Pneumonia Vaccine Market Challenges
Table 19. Pneumonia Vaccine Market Restraints
Table 20. Global Pneumonia Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
Table 21. Global Pneumonia Vaccine Sales Share by Manufacturers (2017-2022)
Table 22. Global Pneumonia Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Pneumonia Vaccine Manufacturers by Revenue (US$ Million) in 2021
Table 24. Pneumonia Vaccine Revenue Share by Manufacturers (2017-2022)
Table 25. Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumonia Vaccine as of 2021)
Table 27. Key Manufacturers Pneumonia Vaccine Average Selling Price (ASP) & (2017-2022) & (USD/Dose)
Table 28. Key Manufacturers Pneumonia Vaccine Plants/Factories Distribution
Table 29. Key Manufacturers Pneumonia Vaccine Area Served
Table 30. Date of Key Manufacturers Enter into Pneumonia Vaccine Market
Table 31. Key Manufacturers Pneumonia Vaccine Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Pneumonia Vaccine Sales (K Doses) by Type (2017-2022)
Table 34. Global Pneumonia Vaccine Sales Share by Type (2017-2022)
Table 35. Global Pneumonia Vaccine Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Pneumonia Vaccine Price (K Doses) by Type (2017-2022)
Table 37. Global Pneumonia Vaccine Sales (K Doses) by Type (2023-2028)
Table 38. Global Pneumonia Vaccine Sales Share by Type (2023-2028)
Table 39. Global Pneumonia Vaccine Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Pneumonia Vaccine Revenue Share by Type (2023-2028)
Table 41. Global Pneumonia Vaccine Price (K Doses) by Type (2023-2028)
Table 42. Global Pneumonia Vaccine Sales (K Doses) by Application (2017-2022)
Table 43. Global Pneumonia Vaccine Sales Share by Application (2017-2022)
Table 44. Global Pneumonia Vaccine Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Pneumonia Vaccine Price (K Doses) by Application (2017-2022)
Table 46. Global Pneumonia Vaccine Sales (K Doses) by Application (2023-2028)
Table 47. Global Pneumonia Vaccine Sales Share by Application (2023-2028)
Table 48. Global Pneumonia Vaccine Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Pneumonia Vaccine Revenue Share by Application (2023-2028)
Table 50. Global Pneumonia Vaccine Price (K Doses) by Application (2023-2028)
Table 51. North America Pneumonia Vaccine Sales by Company (2017-2022) & (K Doses)
Table 52. North America Pneumonia Vaccine Sales Market Share by Company (2017-2022)
Table 53. North America Pneumonia Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Pneumonia Vaccine Revenue Market Share by Company (2017-2022)
Table 55. North America Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 56. North America Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 57. North America Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 60. North America Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 61. North America Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 64. North America Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 65. North America Pneumonia Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Pneumonia Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Pneumonia Vaccine Sales by Company (2017-2022) & (K Doses)
Table 68. Europe Pneumonia Vaccine Sales Market Share by Company (2017-2022)
Table 69. Europe Pneumonia Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Pneumonia Vaccine Revenue Market Share by Company (2017-2022)
Table 71. Europe Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 72. Europe Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 73. Europe Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 76. Europe Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 77. Europe Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 80. Europe Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 81. Europe Pneumonia Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Pneumonia Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Pneumonia Vaccine Sales by Company (2017-2022) & (K Doses)
Table 84. Asia Pacific Pneumonia Vaccine Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Pneumonia Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Pneumonia Vaccine Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 88. Asia Pacific Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 89. Asia Pacific Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 92. Asia Pacific Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 93. Asia Pacific Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Pneumonia Vaccine Sales by Region (2017-2022) & (K Doses)
Table 96. Asia Pacific Pneumonia Vaccine Sales by Region (2023-2028) & (K Doses)
Table 97. Asia Pacific Pneumonia Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Pneumonia Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Pneumonia Vaccine Sales by Company (2017-2022) & (K Doses)
Table 100. Latin America Pneumonia Vaccine Sales Market Share by Company (2017-2022)
Table 101. Latin America Pneumonia Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Pneumonia Vaccine Revenue Market Share by Company (2017-2022)
Table 103. Latin America Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 104. Latin America Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 105. Latin America Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 108. Latin America Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 109. Latin America Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 112. Latin America Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 113. Latin America Pneumonia Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Pneumonia Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Pneumonia Vaccine Sales by Company (2017-2022) & (K Doses)
Table 116. Middle East and Africa Pneumonia Vaccine Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Pneumonia Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Pneumonia Vaccine Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 120. Middle East and Africa Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 121. Middle East and Africa Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 124. Middle East and Africa Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 125. Middle East and Africa Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 128. Middle East and Africa Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 129. Middle East and Africa Pneumonia Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Pneumonia Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 131. Pfizer Inc. Corporation Information
Table 132. Pfizer Inc. Description and Overview
Table 133. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 134. Pfizer Inc. Pneumonia Vaccine Product and Services
Table 135. Pfizer Inc. Pneumonia Vaccine SWOT Analysis
Table 136. Pfizer Inc. Recent Developments
Table 137. Glaxosmithkline Plc. Corporation Information
Table 138. Glaxosmithkline Plc. Description and Overview
Table 139. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 140. Glaxosmithkline Plc. Pneumonia Vaccine Product and Services
Table 141. Glaxosmithkline Plc. Pneumonia Vaccine SWOT Analysis
Table 142. Glaxosmithkline Plc. Recent Developments
Table 143. Merck & Co., Inc. Corporation Information
Table 144. Merck & Co., Inc. Description and Overview
Table 145. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 146. Merck & Co., Inc. Pneumonia Vaccine Product and Services
Table 147. Merck & Co., Inc. Pneumonia Vaccine SWOT Analysis
Table 148. Merck & Co., Inc. Recent Developments
Table 149. Sanofi Pasteur Corporation Information
Table 150. Sanofi Pasteur Description and Overview
Table 151. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 152. Sanofi Pasteur Pneumonia Vaccine Product and Services
Table 153. Sanofi Pasteur Pneumonia Vaccine SWOT Analysis
Table 154. Sanofi Pasteur Recent Developments
Table 155. Serum Institute of India Pvt. Ltd. Corporation Information
Table 156. Serum Institute of India Pvt. Ltd. Description and Overview
Table 157. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 158. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product and Services
Table 159. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine SWOT Analysis
Table 160. Serum Institute of India Pvt. Ltd. Recent Developments
Table 161. Johnson & Johnson Corporation Information
Table 162. Johnson & Johnson Description and Overview
Table 163. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 164. Johnson & Johnson Pneumonia Vaccine Product and Services
Table 165. Johnson & Johnson Pneumonia Vaccine SWOT Analysis
Table 166. Johnson & Johnson Recent Developments
Table 167. Astellas Pharma Inc. Corporation Information
Table 168. Astellas Pharma Inc. Description and Overview
Table 169. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 170. Astellas Pharma Inc. Pneumonia Vaccine Product and Services
Table 171. Astellas Pharma Inc. Pneumonia Vaccine SWOT Analysis
Table 172. Astellas Pharma Inc. Recent Developments
Table 173. Astrazeneca Plc. Corporation Information
Table 174. Astrazeneca Plc. Description and Overview
Table 175. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 176. Astrazeneca Plc. Pneumonia Vaccine Product and Services
Table 177. Astrazeneca Plc. Pneumonia Vaccine SWOT Analysis
Table 178. Astrazeneca Plc. Recent Developments
Table 179. CSL Limited Corporation Information
Table 180. CSL Limited Description and Overview
Table 181. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 182. CSL Limited Pneumonia Vaccine Product and Services
Table 183. CSL Limited Pneumonia Vaccine SWOT Analysis
Table 184. CSL Limited Recent Developments
Table 185. Emergent Biosolutions Corporation Information
Table 186. Emergent Biosolutions Description and Overview
Table 187. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 188. Emergent Biosolutions Pneumonia Vaccine Product and Services
Table 189. Emergent Biosolutions Pneumonia Vaccine SWOT Analysis
Table 190. Emergent Biosolutions Recent Developments
Table 191. Walvax Biotechnology Corporation Information
Table 192. Walvax Biotechnology Description and Overview
Table 193. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 194. Walvax Biotechnology Pneumonia Vaccine Product and Services
Table 195. Walvax Biotechnology Recent Developments
Table 196. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
Table 197. Royal (Wuxi) Bio-Pharmaceutical Description and Overview
Table 198. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 199. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product and Services
Tab

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs